Cargando…
Extreme Thrombocytosis in Refractory ITP Post-Splenectomy With Associated Fatal Thromboembolism
Thrombopoietin (TPO)-receptor agonists have heralded a paradigm shift in the treatment of refractory immune thrombocytopenia (ITP). Reactive thrombocytosis has been described as a secondary effect of such therapies. However, the phenomenon of extreme thrombocytosis with morphology mimicking a myelop...
Autores principales: | Nedumannil, Rithin, Leitinger, Emma, Juneja, Surender |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905198/ https://www.ncbi.nlm.nih.gov/pubmed/35284824 http://dx.doi.org/10.1177/2632010X221083218 |
Ejemplares similares
-
Can post-splenectomy thrombocytosis mask essential thrombocythaemia?
por: Langabeer, Stephen E.
Publicado: (2020) -
Predictive Factors for Success of Laparoscopic Splenectomy for ITP
por: Nyilas, Áron, et al.
Publicado: (2018) -
Essential Thrombocytosis-Associated Thromboembolism in the Abdominal Aorta
por: Chong, Byung Kwon, et al.
Publicado: (2016) -
Balancing Therapy with Thrombopoietin Receptor Agonists and Splenectomy in Refractory Immune Thrombocytopenic Purpura: A Case of Postsplenectomy Thrombocytosis Requiring Plateletpheresis
por: Zimmerman, Jacquelyn, et al.
Publicado: (2016) -
Acute Central Retinal Vein Occlusion Secondary to Reactive Thrombocytosis after Splenectomy
por: Oncel Acir, Nursen, et al.
Publicado: (2014)